Alzchem Group Ag · XETR:ACT
Alzchem — Q2 2024 Earnings Presentation
32 slides from Alzchem's earnings presentation, Aug 1, 2024
Slide 1: Agile Science Pure Results
AGILE SCIENCE PURE RESULTS
Slide 2: Management presenters, August 1, 2024
2 2024 ANDREAS NIEDERMAIER, CEO DR. GEORG WEICHSELBAUMER, CSO ANDREAS LOSLER, CFO August 1, 2024
Slide 3: Disclaimer
DISCLAIMER CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements about the business, financial condition and earnings performance of the Alzchem Group. These statements are based on assumptions and projections resting upon currently available info
Slide 4: Agenda — Analyst Presentation Q2 2024: Executive Summary
AGENDA — ANALYST PRESENTATION Q2 2024 Executive Summary
Slide 5: Highlights
HIGHLIGHTS Strong half year performance leads to an increase in EBITDA outlook Group sales above EBITDA outlook 2024 adjusted: previous year withistrong Further growth to over 100 ME shifts between segments expected Strong increase in EBITDA as a result from sales shifts to Specialty Chemicals Sales
Slide 6: Outlook 2024 (in M€)
OUTLOOK 2024 (in me) Outlook adjusted; strong growth in EBITDA; sales confirmed growth to approx. 570.0 ME FC 2024 Adjustment 2024 growth to over 100.0 Me 2023 FC 2024 Adjustment 2024 COMMENTS * Based on strong half year figures EBITDA outlook was raised * EBITDA expected to increase to over 100 M€
Slide 7: Agenda — Business and financial details
AGENDA — ANALYST PRESENTATION Q2 2024 ll. Business and financial details
Slide 8: Basics & Intermediates
NITRALZ® CBerlka’ G CaD BASICS & INTERMEDIATES The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products for example in agriculture, steel production and the automotive sector and as raw materials for the manufacture of
Slide 9: Basics & Intermediates Segment (in M€)
BASICS & INTERMEDIATES SEGMENT (in Me€) Challenging market environment with stable EBITDA SALES ANALYSIS ——_&p>—_, Q2. Q3 4 QI Q2 QB 4 QI 2 2022 2022 2022 2023 2023 2023 2023 2024 2024 COMMENTS of 12 % in fir: _-: Nitr competition from ing deman: Q2 Q@3 4 Qt Q2. 3 4 QI 2 EBITD, 2022 2022 2022 2023 2
Slide 10: Specialty Chemicals
a oe ( CREAMINO Drmex' Bioselect® DYHARD ##% Creapure* SPECIALTY CHEMICALS The "Specialty Chemicals" segment produces and sells high-quality growth products in the area of specialty chemicals.
Slide 11: Specialty Chemicals Segment (in M€)
SPECIALTY CHEMICALS SEGMENT (in M€) Ongoing growth trend accompanied by profitability increase => SALES ANALYSIS 85.8 73.2 Q2. Q3 -Q4 Qt 2B QA Qs COMMENTS 2022 2022 2022 2023 2023 2023 2023 2024 2024 . Q2. 03 O4 QI Q2 O38 4 QI QR 1-6 1-6 2022 2022 2022 2023 2023 2023 2023 2024 2024 2023 2024 margin:
Slide 12: Other & Holding
The "Other & Holding" segment offers infrastructure and energy supply services a at our locations for the chemicals segments and for external customers. a, . | OTHER & HOLDING
Slide 13: Other & Holding Segment (in M€)
OTHER & HOLDING SEGMENT (in m€) Segment in line with Outlook Q2. Q3_ Q4 QI QZ. QB 4 QI 2 2022 2022 2022 2023 2023 2023 2023 2024 2024 COMMENTS ar Q2. 3) Q4- QI Q2 QB 4 QI QR 1-6 1-6 2022 2022 2022 2023 2023 2023 2023 2024 2024 2023 2024
Slide 14: Financial Overview
FINANCIAL OVERVIEW Continued growth in all major performance figures SALES (in M€) EBITDA (in M€) EBITDA margin (in %) Earnings per Share (in €) ithin six months pi its in EUR millic Improved EBITDA-margin of 18.1% (pri Strong inc in net result and earni result to 286.3 ME nts; volume gi mediates Je
Slide 15: Balance Sheet (in M€)
BALANCE SHEET (in Mé€) Increase in equity and cash dominates balance sheet development Other non-current assets 182.6 Equity Deferred taxes for pension provision 76.2. Other non-current liabilities Inventories Pension provision Trade receivables 82.6 109. Current liabilities [339] Other current asse
Slide 16: Cashflow (in M€)
CASHFLOW (in m€) Strong increase in operating cashflow leads to stable financial position
Slide 17: Financial Calendar
FINANCIAL CALENDAR Upcoming dates* “subject to change SEP 23 SEP 25 NOV 7 NOV 13 NOV 25-26 2024 2024 2024 2024 2024 MS Baader Investment Conference Berenberg and Goldman Sachs German Corporate Conference Quarterly Statement 3? Quarter 2024 Miinchner Kapitalmarkt Konferenz Deutsches Eigenkapitalforum
Slide 18: Feedback
FEEDBACK We appreciate your feedback Were your expectations met? Are you missing any content? WE APPRECIATE YOUR FEEDBACK! QR-Code Teer ela]
Slide 19: Investor Relations
alzchem group Investor Relations T +49 8621 86-2888 F +49 8621 86-502888 ir@alzchem.com
Slide 20: Agenda — Back-Up
AGENDA — ANALYST PRESENTATION Q2 2024 ll. Back-Up
Slide 21: Balance Sheet
© Alzchem Group AG / August 2024 BALANCE SHEET Alzchem Group MS ALZCHEM GROUP (IN TE) 31.12.2023 30.06.2024 Deviation ALZCHEM GROUP (IN TE) 31.12.2023 30.06.2024 Deviation Intangible assets 3,664 3,702 3a 10% Share capital 101763 101,763 Tangible assets W128 19138 185/10 RETAINED EARNINGS (+) / LOSS
Slide 22: Pension Accounting (IFRS)
PENSION ACCOUNTING (IFRS) Alzchem Group (M€) IN FINANCIAL PENSION SERVICE NET INTEREST PENSION PENSION PENSION DEFERRED STATEMENT PROVISION costs costs PAYMENTS REMEASURE- PROVISION TAX ASSETS 31.12.2023 A MENTS 30.06.2024 eiNANciA RESULT BALANCE SHEET P&L CASHFLOW, Interest rates increased from 3.2
Slide 23: Income Statement
© Alzchem Group AG / August 2024 INCOME STATEMENT AN Alzchem Group Gy ALECHEM GROUP(N TE) wos tons 2003s zoe zone te zoe_—_—Devtion(Q2) Revenue 150,432 126599 120,824 142,794 180,064. 136,191 9502 8% Increase (+) / Decrease (-) in inventories of finished goods and work in progress m6 9105 147 13,972
Slide 24: Income Statement
© Alzchem Group AG / August 2024 INCOME STATEMENT i, XW Alzchem Group Gy Q2 Q YTD YTD ALZCHEM GROUP (IN TE) Deviation (QoQ) Deviation (Yoy) 2023 2024 Jun.2023— Jun.2024 Revenue 126,599 136,191 9,592 7.8% 277,031 286,255 9.224 3.3% Increase (+) / Decrease (-) in inventories of finished goods and work
Slide 25: Cashflow Statement
© Alzchem Group AG / August 2024 CASHFLOW STATEMENT Alzchem Group Q Q2 CASHFLOW (IN M€) 2023 2024 ‘Consolidated earnings before taxes 9,982 19,888 Depreciation on fixed and intangible assets 6,335 6,453 Decrease in pension provisions 403 -4n Loss (+) / Profit (-) from the sale of non-current assets
Slide 26: Segment Overview by Quarter
SEGMENT OVERVIEW BY QUARTER Alzchem Group SALES SALES 3 04 Te Te Qi Te Q2 Te O38 Te 04 Te Qi Te Q2 Te Q3 Te O4 Te Deviation PY (22) Te % Basics & Intermediates Specialty Chemicals Other and Holding 59,557 52,614 72,967 73,902 6,670 6,684 -4,190 12,633 1149 -9% 7% 16% Alzchem Group, 129,395 140,435 1
Slide 27: Alzchem Group Locations
ALZCHEM GROUP LOCATIONS Production sites and sales companies COVENTRY (UK) - SHANGHAI (CN) ATLANTA (USA) : . ~ } ® SALES COMPANY © Alzchem Group AG / Aug
Slide 28: Implementing Operating Targets 2024
© Alzchem Group AG / August 2024 IMPLEMENTING OPERATING TARGETS 2024 Focus on the key growth drivers and sustainability IMPROVEMENT * Pass on raw material price increases to the market * Flexibilization of production and processes * Volume growth & full capacity utilization GROWTH * Increase the ava
Slide 29: Verbund — Fully Integrated Business Model
© Alzchem Group AG / August 2024 “VERBUND” — FULLY INTEGRATED BUSINESS MODEL AN Benefits of the “Verbund” system approach tay O O Segment Specialty Chemicals Segment Basics & Inter- mediates BENEFITS OF “VERBUND” * Full control of product quality and specifications * Lower costs * Higher financial p
Slide 30: Our Products and Markets
© Alzchem Group AG / August 2024 OUR PRODUCTS AND MARKETS i, iN Successful with proven and new products in various industries (ay MAIN PRODUCTS DESCRIPTION END-MARKETS CREAMINO®’ = Anutritional additive for poultry and pigs Feed additive Creapure’ Creapure®, premium brand for creatine monohydrate as
Slide 31: Our Products and Markets
© Alzchem Group AG / August 2024 OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries \N Pharmaceutical MAIN PRODUCTS DESCRIPTION END-MARKETS @ Calcium carbide-based mixtures for hot metal desulphurization Steel industry ny Guanidine Salts Fuel for airbags, key prod
Slide 32: Key Share Data
© Alzchem Group AG / August 2024 KEY SHARE DATA Share details as of July 30, 2024 SHARES OUTSTANDING LAST CLOSING PRICE MARKET CAPITALIZATION TICKER WKN ISIN LISTING DESIGNATED SPONSOR 10,176,335 EUR 49.80 EUR 507m ACT A2YNT3 DEOOOA2YNT30 Frankfurt Stock Exchange — Prime Standard Baader Bank AG ODDO